News &amp; Updates

Intensive management of blood pressure (BP) leads to a significant reduction in cardiovascular events in overweight, obese I, and obese II patients without elevating safety risks, a study has shown.

23 May 2022

Steroid plus anti-TNF-α proven effective in SJS/TEN

The addition of antitumour necrosis factor-alpha (anti-TNF-α) to steroid treatment may help improve outcomes for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), suggest the results of a recent study.

Upadacitinib provides robust, long-term control of moderate-to-severe AD

Follow-up data from two replicate ongoing phase III trials – Measure Up 1 and Measure Up 2 – demonstrated favourable longer-term benefit-risk profile of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis (AD).

23 May 2022

Different booster shot strengthens immune response against Omicron

Getting a different type of mRNA vaccine for the booster shot leads to a stronger neutralizing immune response against the COVID-19 Omicron variant, according to a recent Singapore study.

23 May 2022

Obesity, sleep apnoea do not contribute to increased sarcoidosis risk

Increased body mass index does not seem to raise the risk of developing sarcoidosis, according to a study. Furthermore, the presence of obstructive sleep apnoea even confers protection.

Cancer patients more vulnerable to PTSD during pandemic

Cancer patients may be more susceptible to developing symptoms of post-traumatic stress disorder (PTSD), especially amid the COVID-19 pandemic, reports a recent study.

23 May 2022

Keto diet: Is there good evidence in MS?

A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.

23 May 2022

High BNP predicts stroke or systemic embolism in very elderly NVAF patients

In very elderly nonvalvular atrial fibrillation (NVAF) patients who are ineligible for standard anticoagulation, increasing levels of B-type natriuretic peptide (BNP) appear to be correlated with higher risks of stroke or systemic embolism, reports a new study.

$Early initiation of anti-osteoporosis medication reduces fracture events$

Early initiation of anti-osteoporosis medication reduces fracture events

For patients on glucocorticoid therapy, a delay in anti-osteoporosis treatment initiation may lead to increased fracture events, while early treatment helps to prevent them, a study has found.

Which canagliflozin dose is best for T2DM patients with hypertension?